About Diploid
Diploid is a Healthcare company based in Leuven (Belgium) founded in 2014, and was acquired by Invitae in March 2020. Software for diagnosing rare diseases is provided using machine learning. Diploid offers products and services including Oncology Genetic Tests, Women's Health Tests, and Pediatrics and Rare Diseases Tests. Its focus areas include Life Sciences, Genomics, Genome Informatics and Sequence Analysis.
Company details
Diploid was founded in 2014 in Leuven, Belgium, as a health technology company focused on genomics. A proprietary machine-learning algorithm is utilized to analyze patient data from next-generation sequencing for rare disease diagnosis. GentleLabs is also operated as a direct-to-consumer service, where saliva samples are tested for over 1700 genetic disorders and results are sent to physicians.
Products & Services of Diploid
Diploid offers a comprehensive portfolio of products and services, including Oncology Genetic Tests, Women's Health Tests, and Pediatrics and Rare Diseases Tests.
Tests for identifying genetic risks in cancer patients
Genetic tests for hereditary women's health conditions
Assessments for rare genetic conditions in children
Investors in Diploid
Diploid has secured backing from 1 investor. Prominent investors backing the company include Invitae.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Home-based genetic tests for detecting diseases are provided to individuals. | 2010 | invitae.com | San Francisco, United States |
Investor details for Diploid
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Diploid
2 dated milestones of Diploid across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Diploid is founded.
- Exit Acquired by Invitae.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Diploid
Complete news archive for Diploid
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Diploid
Diploid was founded in 2014.
Diploid is headquartered in Leuven, Belgium. It is registered at Leuven, Flemish Brabant, Belgium.
Diploid was founded in 2014 in Leuven, Belgium, as a health technology company focused on genomics. A proprietary machine-learning algorithm is utilized to analyze patient data from next-generation sequencing for rare disease diagnosis. GentleLabs is also operated as a direct-to-consumer service, where saliva samples are tested for over 1700 genetic disorders and results are sent to physicians.
Diploid offers Oncology Genetic Tests, Women's Health Tests, and Pediatrics and Rare Diseases Tests.
Diploid has 1 investor. Key investors include Invitae.
Yes. Diploid was acquired by Invitae in March 2020.